课题基金 / 基金详情

项目摘要

项目成果

Nicholas James Maness的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION: HIV establishes latent infection, hampering efforts for a complete cure. The possibility of such a cure rests on new strategies to identify, quantify and ultimately eliminate latently infected cells. An ideal approach would be to identify latently infected cells and eliminae them without the need to reactivate the latent virus. Here, we posit the existence of a novel marker of latently infected cells, based on new insights into HIV and SIV transcription and translation. Specifically, we hypothesize that latent infection is associated with increased levels of viral antisense transcription and translation. Published data on HIV and our preliminary data with SIV infection of rhesus macaques indicate that antisense transcription in infected CD4+ T cells is more prominent when the cells are less activated, and that many of these unique transcripts are polyadenylated and could be translated. Further, we have identified T cell responses mounted during SIV and HIV infection that target surprisingly conserved peptides derived from translation of antisense transcripts. To test our hypothesis, in Aim 1, we will compare viral transcription (sense and antisense) between latently infected CD4 T cells and activated and infected CD4 T cells using both SIV-infected rhesus macaque and HIV-1 infected human cells. To do this, we will use a novel strand-specific deep sequencing approach. Results from Aim 1 will focus our efforts in Aim 2. In Aim 2, we will use T cells that recognize antisense-encoded epitopes and measure their ability to kill latently infected vs. activated and infected CD4 T cells. In sum, this proposal has the potential to identify a novel marker of latently infecte cells and suggest a means by which to eliminate them. These data could prove important to efforts to develop a cure for HIV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pan Coronavirus Genomic Surveillance of a Large NHP Colony
  • 批准号:
    10575848
  • 项目类别:
  • 资助金额:
    $8.75万
  • 财政年份:
    2022
  • 负责人:
    Nicholas James Maness
  • 依托单位:
T cell modulation of COVID-19 disease
  • 批准号:
    10674085
  • 项目类别:
  • 资助金额:
    $21.88万
  • 财政年份:
    2021
  • 负责人:
    Nicholas James Maness
  • 依托单位:
T cell modulation of COVID-19 disease
  • 批准号:
    10239822
  • 项目类别:
  • 资助金额:
    $25.5万
  • 财政年份:
    2021
  • 负责人:
    Nicholas James Maness
  • 依托单位:
T cell modulation of COVID-19 disease
  • 批准号:
    10491340
  • 项目类别:
  • 资助金额:
    $21.25万
  • 财政年份:
    2021
  • 负责人:
    Nicholas James Maness
  • 依托单位:
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: